Announcements Trials
Browse Landscape

Status

Completed 145Recruiting 123Unknown 85Terminated 27Active not recruiting 23Not yet recruiting 20Withdrawn 17Enrolling by invitation 4Suspended 2

Sponsor Class

OTHER 4

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Myeloid 1Lymphoid 1Head & Neck 1Breast 1

Conditions

Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Myelitis, Transverse 1Myasthenia Gravis 1Multiple Sclerosis 1Lymphoproliferative Disorders 1Head and Neck Neoplasms 1Breast Neoplasms 1Autoimmune Diseases 1

Interventions

Specimen Handling 5Surveys and Questionnaires 4Observation 4Blood Specimen Collection 4Drug Therapy 3Chemoradiotherapy 3Surgical Procedures, Operative 2Electrocardiography 2Echocardiography 2Capecitabine 2Biopsy 2trifluridine tipiracil drug combination 1tegafur-gimeracil-oteracil 1somapacitan 1olverembatinib 1lorlatinib 1lenvatinib 1gallium 68 PSMA-11 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1Zoledronic Acid 1Tumor Burden 1Telemedicine 1Tegafur 1Stents 1Spermine Synthase 1S 1 (combination) 1Robotic Surgical Procedures 1Rituximab 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Blood Specimen Collection × Clear all
NCT00704626 2026-05-18

SAA

University of California, Davis

Enrolling by invitation
120 enrolled

Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myelitis, Transverse

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

OHSU Knight Cancer Institute

Enrolling by invitation
5,000 enrolled
LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT01173341 2026-02-09

Cardiotoxicity of Cancer Therapy (CCT)

Abramson Cancer Center at Penn Medicine

Enrolling by invitation
700 enrolled
Breast

Breast Neoplasms

NCT06809673 2025-02-05

PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial

Ospedale Policlinico San Martino

Enrolling by invitation
400 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡